Id |
Subject |
Object |
Predicate |
Lexical cue |
T23 |
0-7 |
Sentence |
denotes |
METHODS |
T24 |
9-26 |
Sentence |
denotes |
IVIG Preparations |
T25 |
27-139 |
Sentence |
denotes |
A total of 54 IVIG lots fractionated from plasma collected prior to the circulation of SARS-CoV-2 were analyzed. |
T26 |
140-444 |
Sentence |
denotes |
The IVIG lots were manufactured from plasma either donated by plasmapheresis (source) or recovered from whole-blood donations (recovered), in the United States (Gammagard Liquid; Baxter Healthcare Corp.; n = 30) or central Europe, that is Austria, Germany, and Czech Republic (KIOVIG; Baxter AG; n = 24). |
T27 |
445-579 |
Sentence |
denotes |
These 54 IVIG lots were tested in 2 independent experiments for nAbs (1 European lot was in a single assay due to volume constraints). |
T28 |
581-601 |
Sentence |
denotes |
Human Plasma Samples |
T29 |
602-691 |
Sentence |
denotes |
Two prepandemic plasma donations were collected in April and May 2019 by BioLife Austria. |
T30 |
692-850 |
Sentence |
denotes |
Human plasma pool samples were generated by the combination of 6 individual donations obtained in the same week at Austrian plasma donation centers (BioLife). |
T31 |
851-1123 |
Sentence |
denotes |
The pools were assembled from donations collected in week 13 (last week of March; n = 40), week 14 (n = 80), week 15 (n = 80), week 16 (n = 80), week 20 (n = 100), week 24 (n = 80), and week 28 (first week of July; n = 100) of 2020, that is during the SARS-CoV-2 pandemic. |
T32 |
1124-1350 |
Sentence |
denotes |
Cumulative incidence of COVID-19 was calculated from data provided by the Austrian Federal Ministry for Social Affairs, Health, Care and Consumer Protection (www.sozialministerium.at) and Statistics Austria (www.statistik.at). |
T33 |
1352-1399 |
Sentence |
denotes |
Detection of SARS-CoV-2 Neutralizing Antibodies |
T34 |
1400-1640 |
Sentence |
denotes |
SARS-CoV-2 nAb titers were determined in IVIG and human plasma samples that were used undiluted, or prediluted with cell culture medium 1:4, 1:5, 1:10, or 1:20 depending on sample amount available, and then serially diluted in 2-fold steps. |
T35 |
1641-1829 |
Sentence |
denotes |
Equal volumes of sample dilutions were mixed with virus stock at 103.0 tissue culture infectious doses 50% per milliliter (TCID50/mL) SARS-CoV-2 (strain BavPat1/2020, kindly provided by C. |
T36 |
1830-1844 |
Sentence |
denotes |
Drosten and V. |
T37 |
1845-1962 |
Sentence |
denotes |
Corman, Charité Berlin, Germany) and incubated for 150 minutes ± 15 minutes, before titration on Vero cells (Cat. no. |
T38 |
1963-2087 |
Sentence |
denotes |
84113001, European Collection of Authenticated Cell Cultures, Porton Down, Salisbury, UK) in 8-fold replicates per dilution. |
T39 |
2088-2168 |
Sentence |
denotes |
The virus-induced cytopathic effect was determined after 5–7 days of incubation. |
T40 |
2169-2372 |
Sentence |
denotes |
The reciprocal sample dilution resulting in 50% virus neutralization (NT50) was determined using the Spearman-Kärber formula, and the calculated neutralization titer for 50% of the wells reported as 1:X. |
T41 |
2373-2552 |
Sentence |
denotes |
The detection limits were as follows: <1:0.8 for undiluted, <1:3.1 for 1:4 prediluted, <1:3.9 for 1:5 prediluted, <1:7.7 for 1:10 prediluted, and <1:15.4 for 1:20 prediluted IVIG. |
T42 |
2553-2804 |
Sentence |
denotes |
The neutralization assay (µNT) included several validity criteria, that is confirmatory titration of input virus infectivity, cell viability, and neutralization testing of an internal reference standard, all of which had to comply with defined ranges. |
T43 |
2806-2852 |
Sentence |
denotes |
Detection of HCoV-229E Neutralizing Antibodies |
T44 |
2853-3088 |
Sentence |
denotes |
The neutralization assay for HCoV-229E antibodies is essentially identical to the SARS-CoV-2, where samples were used undiluted or prediluted, then serially diluted in 2-fold steps and mixed 1:2 with 103.0 TCID50/mL HCoV-229E (Cat. no. |
T45 |
3089-3202 |
Sentence |
denotes |
VR-740, American Type Culture Collection [ATCC], Rockville, MD), incubated, and titrated on MRC-5 cells (Cat. no. |
T46 |
3203-3233 |
Sentence |
denotes |
CCL-171, ATCC, Rockville, MD). |
T47 |
3234-3314 |
Sentence |
denotes |
The virus-induced cytopathic effect was determined after 7–9 days of incubation. |
T48 |
3316-3347 |
Sentence |
denotes |
Graphs and Statistical Analysis |
T49 |
3348-3460 |
Sentence |
denotes |
Graphical illustration and statistical analysis (paired t tests) were done using GraphPad Prism v8.1.1 software. |